LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 93.92 | 21.74 | 8482 | 6070 | 1.3974 | 1.0841 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 93.92 | 21.74 | 8524 | 6070 | 1.4043 | 1.0853 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 93.92 | 21.74 | 7409 | 6070 | 1.2206 | 1.0497 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 93.92 | 21.74 | 7480 | 6070 | 1.2323 | 1.0521 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 93.92 | 21.74 | 1056 | 6070 | 0.1740 | 0.6127 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 93.92 | 21.74 | 9497 | 6070 | 1.5646 | 1.1133 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 2.24 | 21.74 | 679 | 183 | 3.6988 | 2.0591 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 2.24 | 21.74 | 687 | 183 | 3.7424 | 2.0707 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.24 | 21.74 | 850 | 317 | 2.6748 | 1.5790 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.24 | 21.74 | 843 | 317 | 2.6527 | 1.5735 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.21 | 21.74 | 946 | 392 | 2.4133 | 1.4702 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.21 | 21.74 | 931 | 392 | 2.3750 | 1.4607 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 8.19 | 21.74 | 14 | 439 | 0.0318 | -0.0965 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 8.19 | 21.74 | 1018 | 439 | 2.3144 | 1.4268 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 8.19 | 21.74 | 1002 | 439 | 2.2780 | 1.4179 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 10.16 | 21.74 | 22 | 463 | 0.0475 | 0.0027 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 10.16 | 21.74 | 1055 | 463 | 2.2755 | 1.4094 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | N13 |